Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
International Urology and Nephrology|July 5, 2017
FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapyE E Fransen van de Putte, E Vegt, L S Mertens, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 7, 2020
A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneityVivian P Bastiaenen, Charlotte E L Klaver, Maartje C S van der Heijden, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 17, 2024
The association between childhood trauma and tobacco smoking in patients with psychosis, unaffected siblings, and healthy controlsJustine de With, Heleen S van der Heijden, Therese van Amelsvoort, et al.
British Journal of Cancer|December 15, 2023
Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptationBastiaan J Viergever, Daniëlle A E Raats, Veerle Geurts, et al.
Cancer Treatment and Research Communications|December 14, 2020
Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort studyAnke Richters, Niven Mehra, Richard P Meijer, et al.
European Urology Focus|September 18, 2021
Overall Survival of Patients Receiving Cisplatin or Carboplatin for Primary Metastatic Urothelial Carcinoma of the Bladder: A Contemporary Dutch Nationwide Cohort StudyAnke Richters, Joost L Boormans, Michiel S van der Heijden, et al.
European Urology|September 18, 2017
Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial CancerBernadett Szabados, Nick van Dijk, Yen Zhi Tang, et al.
Genome Medicine|March 21, 2025
Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implicationsDaniel J Vis, Sander A L Palit, Marie Corradi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 10, 2020
Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: A convenient alternative to 5-fluorouracilCharlotte S Voskuilen, Maaike W van de Kamp, Nannet Schuring, et al.
European Urology|January 22, 2017
A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell CarcinomaLiqin Wang, Tonći Šuštić, Rodrigo Leite de Oliveira, et al.
Pageof 15